Published in Hum Immunol on April 01, 1999
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis (2001) 1.94
Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion (2014) 1.38
Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands. J Biol Chem (2010) 1.27
Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol (2003) 1.11
Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. PLoS One (2013) 0.93
Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model. Cell Stress Chaperones (2010) 0.89
Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPs. Am J Reprod Immunol (2009) 0.89
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunol (2012) 0.86
Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes. Biomed Res Int (2013) 0.84
Estradiol regulates MICA expression in human endometrial cells. Clin Immunol (2008) 0.84
Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient. Pediatr Transplant (2010) 0.82
Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol (2013) 0.82
Association of MICA gene polymorphisms with liver fibrosis in schistosomiasis patients in the Dongting Lake region. Braz J Med Biol Res (2012) 0.77
Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases. Open Rheumatol J (2015) 0.76
Genetic Diversity and mRNA Expression of Porcine MHC Class I Chain-Related 2 (SLA-MIC2) Gene and Development of a High-Resolution Typing Method. PLoS One (2015) 0.75
Genetic barriers in transplantation medicine. World J Transplant (2016) 0.75
Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation. Front Immunol (2017) 0.75
MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? Front Immunol (2017) 0.75
Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study. Clin Rheumatol (2017) 0.75
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97
Medical evaluation of internationally adopted children. N Engl J Med (1991) 3.84
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest (1976) 2.84
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A (1980) 2.61
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Unsuspected infectious diseases and other medical diagnoses in the evaluation of internationally adopted children. Pediatrics (1989) 2.12
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
The health of children adopted from Romania. JAMA (1993) 2.00
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
A new antigen system expressed in human endothelial cells. J Clin Invest (1977) 1.79
Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics (1998) 1.43
Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest (1979) 1.38
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
The human immune response region (HLA-D) and disease susceptibility. Immunol Rev (1983) 1.24
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. J Immunol (1983) 1.22
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 1.20
Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol (2000) 1.18
HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplant Proc (1977) 1.15
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry (2000) 1.13
HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.12
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Immunogenetic factors in preeclampsia and eclampsia. Erythrocyte, histocompatibility, and Y-dependent antigens. JAMA (1976) 1.11
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol (1992) 1.10
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol (1986) 1.09
Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol (1984) 1.06
Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets. Immunogenetics (1982) 1.06
Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology (1995) 1.05
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol (2001) 1.04
HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol (1988) 1.04
Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum (1974) 1.03
Family-aided assertive community treatment: a comprehensive rehabilitation and intensive case management approach for persons with schizophrenic disorders. New Dir Ment Health Serv (1992) 1.03
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus. Arthritis Rheum (1972) 1.01
Contribution of family, cognitive and clinical dimensions to long-term outcome in schizophrenia. Schizophr Res (1992) 1.00
Monoclonal antibodies against human monocytes. II. Recognition of two distinct cell surface molecules. Scand J Immunol (1982) 0.97
Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol (1985) 0.97
Lymphocyte and platelet autoantibodies in S.L.E. Lancet (1971) 0.97
Restriction fragment length polymorphism of the gene encoding the alpha chain of the human T cell receptor. J Exp Med (1985) 0.96
Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med (1988) 0.96
Development of immunological memory during the primary immune response. Nature (1967) 0.95
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med (1988) 0.94
Juvenile arthritis and autoimmunity to type II collagen. Arthritis Rheum (2001) 0.94
High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest (1981) 0.93
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens (1991) 0.93
Genetic markers for susceptibility to endemic Brazilian pemphigus foliaceus (Fogo Selvagem) in Xavante Indians. Tissue Antigens (1993) 0.93
Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens (1993) 0.93
Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production. Clin Immunol Immunopathol (1983) 0.92
Successful kidney trasnplant in patient with positive crossmatch due to autoantibodies. Transplantation (1976) 0.92
Study of HLA antigens in ten multiple-case rheumatoid arthritis families. J Rheumatol (1984) 0.91
Dissimilar evolution of B-locus versus A-locus and class II loci of the HLA region in South American Indian tribes. Tissue Antigens (1997) 0.89
HL-A antigens in mummified pre-Columbian tissues. Science (1974) 0.89
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4. Hum Immunol (1990) 0.89
Evolution of HLA-class I compared to HLA-class II polymorphism in Terena, a South-American Indian tribe. Hum Immunol (1999) 0.89
A comparison of two levels of family-aided assertive community treatment. Psychiatr Serv (1996) 0.88
DQA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol (1994) 0.88
HLA class II DNA typing in two Brazilian populations. Tissue Antigens (1993) 0.87
Stimulation of gamma-globulin synthesis and specific antibody production by a factor released by activated lymphocytes. J Immunol (1973) 0.87
Associations between HLA class II alleles in a North Indian population. Tissue Antigens (1998) 0.86
Comparisons of dialysis and transplant results from one center. Transplant Proc (1979) 0.86
Homologous disease in the adult rat, a model for autoimmune disease. II. Findings in the joints, heart, and other tissues. J Exp Med (1965) 0.86
Role of MICA in the immune response to transplants. Tissue Antigens (2010) 0.86
Diversity of HLA-DR2 in North Indians: the changed scenario after the discovery of DRB1*1506. Tissue Antigens (1998) 0.86
Gender differences in cognition in schizophrenia. Schizophr Res (1992) 0.85
Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock (1999) 0.85
Role of HLA-B and C alleles in development of psoriasis in patients from North India. Tissue Antigens (1998) 0.85
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. II. Typing for alleles of the DRw52-associated group. Hum Immunol (1990) 0.84
Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry (1986) 0.84
HLA-DPB1*0301 is a major risk factor for rheumatoid factor-negative adult rheumatoid arthritis. Arthritis Rheum (1991) 0.84
Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP. Int J Immunogenet (2007) 0.84
Restriction fragment length polymorphism of the human T cell receptor alpha gene. I. Two polymorphic restriction sites localized to different regions of the gene. Immunogenetics (1987) 0.84
Antigen-specific HLA-restricted human T-cell lines. II. A GAT-specific T-cell line restricted by a determinant carried by an HLA-DQ molecule. Immunogenetics (1984) 0.83
Comparison of HLA class II alleles in Gypsy and Czech populations by DNA typing with oligonucleotide probes. Tissue Antigens (1992) 0.83
Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation. Immunogenetics (1985) 0.83
Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR. Immunogenetics (1984) 0.83
Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J Rheumatol (1991) 0.83
Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury. J Clin Invest (1981) 0.82